# Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer

> **NCT00054626** · PHASE3 · UNKNOWN · sponsor: **Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy** · enrollment: 700 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** gemcitabine hydrochloride
- **PROCEDURE:** adjuvant therapy

## Key facts

- **NCT ID:** NCT00054626
- **Lead sponsor:** Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2001-09
- **Primary completion:** 2008-06
- **Final completion:** —
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2013-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00054626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00054626, "Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00054626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*